This Vice President will be instrumental in crafting both the US disease strategies and brand strategies for our priority hematology and solid tumor assets and will lead the development of comprehensive commercial and portfolio strategies in collaboration with global teams and cross-functional leaders.
Base: $330,900.00 - $420,900.00 annually; Bonus/Equity: eligible to participate in an incentive compensation plan and discretionary equity awards; Benefits: comprehensive benefits package
Must-have
Nice-to-have
Not specified